Skip to content

Preventing functional decline in allogeneic bone marrow transplant: the BOOST study

Feasibility of an early commencing hospital-based exercise program to prevent functional decline in people with haematological malignancy treated with allogeneic bone marrow transplant: the BOOST study

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000888268
Acronym
BOOST
Enrollment
42
Registered
2018-05-28
Start date
2018-10-25
Completion date
2019-04-30
Last updated
2021-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of this study is determine the feasibility of an inpatient and subsequent home based exercise and education program for patients undergoing allogeneic bone marrow transplant for haematological cancer at the Royal Melbourne Hospital. Who is it for? You may be eligible for this study if you are an adult aged 18 years or above, planned to undergo an allogeneic bone marrow transplant for haematological cancer at the Royal Melbourne Hospital. Study details All participants will receive a protocolised exercise and education program for the duration of their inpatient admission for their allogeneic bone marrow transplant (alloBMT). The program will include aerobic and resistance training at an individualised level, provided by a physiotherapist in a supervised group setting. The sessions will operate for up to 1-hour up to 5-days per week. Measurement of physical function, physical activity levels, health-related quality of life and body composition will be completed at four time-points: (1) recruitment to the study (approximately 1 month pre-alloBMT); (2) hospital admission; (3) hospital discharge (usually one month after admission); and, (4) 60 days post-alloBMT. We will also obtain consumer feedback through questionnaires and interviews, and look at health care resource usage. This study will provide important information to generate evidence to target our resources in an attempt to minimise physical burden associated with haematological (blood) cancer.

Interventions

All participants will receive a protocolised exercise and education program for the duration of their inpatient admission for their allogeneic bone marrow transplant (alloBMT). The program will include both aerobic and resistance training, to maximise health benefits as per international exercise guidelines, provided by a physiotherapist in a supervised group setting. Each patient will receive individualised exercise based on their self-reported well-being and their objectively measured function

All participants will receive a protocolised exercise and education program for the duration of their inpatient admission for their allogeneic bone marrow transplant (alloBMT). The program will include both aerobic and resistance training, to maximise health benefits as per international exercise guidelines, provided by a physiotherapist in a supervised group setting. Each patient will receive individualised exercise based on their self-reported well-being and their objectively measured functional exercise capacity. A “traffic light” system will be used where patients can be grouped into three categories based on their self-rated well-being at each session (red, yellow and green) in order to tailor the exercise intervention (as described by Wiskemann et al, Blood, March 2011: 117; 9). The target intensity will be 3-5 on the Modified Borg scale of breathlessness for aerobic exercise, and 12-14 on the Rating of Perceived Exertion (RPE) scale for resistance exercise. The sessions will operate for up to 1-hour up to 5-days per week in the recreation room on the Bone Marrow Transplant hospital ward. Equipment to be used already exists on the ward and includes an exercise bike, treadmill, hand weights, steps and arm ergometer. Adherence to the exercise program will be recorded by the physiotherapist in the participant's exercise log; participant's will have their own exercise diary to encourage compliance with the program during their hospital stay and upon discharge from hospital. Education will be integrated into the program through a weekly session facilitated by a different member of the multi-disciplinary team for approximately 20-minutes after the exercise session. Topics will include nutrition, staying motivated, return to work.

Sponsors

Royal Melbourne Hospital
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

The safety of each participant to participate in exercise will be assessed daily on an individual basis. In order to participate in group exercise on any given day, participant's must fulfil the following safety criteria: - Vital observations within normal limits as per hospital protocol - Platelet count greater than or equal to 15 x 10^9/L (resistance exercise can commence when platelet count is 20 or greater) - Haemoglobin count greater than 80 g/L - If a participant is in contact isolation, they may participate in group exercise if they wear gloves; if a participant is in respiratory isolation, they may not participate in group exercise. - Note, as the exercise group takes place on a pressurised ward there is no contraindication to group exercise with low neutrophil count. - Note, all participants are advised to practice hand hygiene and clean equipment before/after use.

Exclusion criteria

Severe active psychiatric or cognitive disorder or unable to provide consent; presence of a musculoskeletal co-morbidity preventing exercise.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026